| Literature DB >> 35527300 |
Nebiyu Mengistu1, Habtamu Endashaw Hareru2, Seid Shumye3, Solomon Yimer3, Daniel Sisay2, Abdene Weya Kaso2, Temesgen Muche4, Chalachew Kassaw3, Negasa Eshete Soboksa2, Wondwosen Molla5, Alemayehu Molla3, Bereket Duko6.
Abstract
BACKGROUND: People living with HIV/AIDS (PLWHA) are frequently confronted with severe social issues such as rejection, abandonment, criticism, and stigma. This would negatively affect their quality of life. Several studies have been conducted so far to assess factors affecting the health-related quality of life among people living with HIV/AIDS who are on antiretroviral therapy (ART) in Ethiopia. However, to our knowledge, there is no previous study that has summarized the results of the studies that investigated health-related quality of life (HRQOL) among PLWHA in Ethiopia. Therefore, the purpose of this review was to estimate the pooled prevalence of HRQOL and its association with social support among people living with HIV/AIDS (PLWHA) on ART in Ethiopia.Entities:
Keywords: Antiretroviral therapy; Ethiopia; HIV/AIDS; Quality of life; Social support
Mesh:
Year: 2022 PMID: 35527300 PMCID: PMC9080185 DOI: 10.1186/s12955-022-01985-z
Source DB: PubMed Journal: Health Qual Life Outcomes ISSN: 1477-7525 Impact factor: 3.077
Fig. 1PRISMA flow diagram describes the selection of studies for a systematic review and meta-analysis of health-related quality of life of people with HIV/AIDS on ART and its association with social support for HIV/AIDS on ART in Ethiopia, 2021
Summary table for the prevalence of poor health-related quality of life of people living with HIV/AIDS on highly active antiretroviral therapy in Ethiopia included in the systematic review and meta-analysis (2021)
| Authors | Region | Publication year | Study area | Sample size | Response rate | Prevalence of poor HRQOL | Assessment tool | Quality assessment |
|---|---|---|---|---|---|---|---|---|
| Amare A et al | Amhara | 2013 | Bahirdar | 424 | 100 | 56.4 | None | 7 |
| Ayalew MB et al | Amhara | 2019 | Gonder | 287 | 100 | 27 | WHO QOL-HIV-BREF | 9 |
| Mohammed SA et al | Amhara | 2021 | Dessie | 251 | 93.62 | 57.4 | MOS-HIV health survey | 8 |
| Surur A et al | Amhara | 2017 | Gondar | 403 | 99.2 | 17.25 | WHOQOL-HIV BREF | 6 |
| Ayeno D et al | Oromia | 2020 | Ambo | 340 | 87 | 53 | WHOQOL-HIV BREF | 7 |
| Negera Z et al | Oromia | 2019 | Jimma | 97 | 97.9 | 58.9 | WHOQOL-HIV BREF | 7 |
| Tesfaye T et al | Oromia | 2018 | Jimma | 351 | 100 | 40.7 | SF-36 | 8 |
| Weldsilase YA et al | Oromia | 2018 | Jimma | 377 | 91 | 53.5 | WHOQOL-HIV BREF | 8 |
| Desta A et al | SNNPR | 2020 | Mizan-Tepi | 311 | 77.2 | 42.9 | WHOQOL-HIV BREF | 6 |
| Tesemma L et al | SNNPR | 2019 | ArbaMinch | 416 | 94 | 47.1 | WHOQOL-HIV BREF | 7 |
Fig. 2Forest plot for the pooled prevalence of poor quality of life of people living with HIV/AIDS on highly active antiretroviral therapy in Ethiopia (2021)
Subgroup analysis of the prevalence of poor quality of life among peoples living with HIV/AIDS on highly active antiretroviral therapy in Ethiopia (2021) (n = 10)
| Variables | Characteristics | Included studies | Prevalence rate [95% CI] |
|---|---|---|---|
| Region | Amhara | 4 | 39.45 [18.64–60.24] |
| Oromia | 4 | 51.01 [43.42–58.60] | |
| SNNPR | 2 | 45.45 [41.44–49.47] | |
| Publication year | ≤ 2018 | 2 | 38.08 [14.08–62.08] |
| > 2018 | 8 | 48.32 [39.78–56.86] | |
| Sample size | < 326 | 4 | 46.28 [30.72–61.87] |
| > 326 | 6 | 44.60 [30.87–58.34] | |
| Overall | 10 | 45.27 [35.37–55.16] |
Fig. 3Sensitivity analysis showing the pooled proportion when the studies were omitted step by step
Fig. 4The pooled odds ratio of the association between HRQOL and social support of patients with HIV/AIDS on ART in Ethiopia, 2021